Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06121115
NCT06121115CompletedNot Applicable

Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit - a Retrospective Study of Complications and Patient Outcomes

Region Skane1 site in 1 country473 target enrollmentStarted: October 3, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
473
Locations
1
Primary Endpoint
Proportion of patients with a major complication of norepinephrine administration in midline
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a single-center study retrospectively evaluating a local clinical routine to administer norepinephrine in midline catheters, with regard to complications and patient outcomes

Detailed Description

Se attached study protocol

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Administration of norepinephrine in a midline catheter in an intermediary care unit
  • •In Skåne university hospital
  • •From 2019 to 2023-03-31

Exclusion Criteria

  • •Patients who have actively disabled review of their electronic medical record

Outcomes

Primary Outcomes

Proportion of patients with a major complication of norepinephrine administration in midline

Time Frame: day 30

extravasation of norepinephrine, midline-associated bloodstream infection, thrombosis

Secondary Outcomes

  • Proportion of patients receiving a CVC after midline(day 30)
  • Proportion of patients with a minor complication of norepinephrine administration in midline(day 30)
  • Proportion of patients with different intermediary care unit outcomes(day 30)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Phase 2
Adrenomedullin for CADASI
JPRN-jRCT2051210117Ihara Masafumi60
Completed
Phase 1
Single Dose Study of MK-6482 in Healthy Japanese Female ParticipantsRenal Cell Carcinoma
JPRN-jRCT2031220024Tanaka Yoshiyuki24
Not yet recruiting
Phase 2
se of Dashmool trivrita tail uttarbasti in udavrutta yonivyapad ( Dysmenorrhea)as a painkiller
CTRI/2023/02/049611DR. DURGESHWARI RAUT
Completed
Not Applicable
Single-center Retrospective Confirmatory Clinical study to Evaluate the Efficacy of Retinal-based Cardiovascular Risk Assessment Software as Medical Device (SaMD) DrNoon for CVD
KCT0007047Medi Whale1,106
Completed
Not Applicable
Paediatric accelerator mass spectrometry evaluation research study
ISRCTN24569018iverpool Women's NHS Foundation Trust (UK)60